← Eichor
Study identifier: NCT07244445 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Pistachio Intake and Nutrition-Related Outcomes in Individuals on GLP-1 Therapy

Condition: Dietary Change · Obesity & Overweight · Food Acceptance  ·  Sponsor: Ian J. Neeland, MD

PhaseNA
Planned participants108
Who can joinAll sexes, 18 Years to 80 Years
Healthy volunteersYes

About this study

In this study will look at how eating pistachios every day might affect participants weight, how healthy their diet is, and how they feel when eating. Investigators want to see if adding pistachios to meals for 12 weeks helps participants feel fuller, have more energy, and improve body composition. The study will include adults who have been taking GLP-1 medicines like semaglutide or tirzepatide for at least three months. Investigators also want to see if eating pistachios improves overall diet quality and health markers like tiredness and certain levels in blood.

This description comes directly from the study's public registry record.

Talk to the study team

Ian Neeland, MD  ·  216-844-5965  ·  Ian.Neeland@UHhospitals.org

Abigail Raffner, PhD, RD, LD  ·  216-368-0756  ·  Abigail.Raffner@UHhospitals.org

Always discuss trial participation with your own doctor first.

Locations (1)

University Hospitals Cleveland Medical CenterClevland, Ohio, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07244445